Calponin 3 is an F-actin-binding protein and plays a key role in regulating spine plasticity and synaptic activity in neurons. Unlike the other subtypes, calponin 1 and 2, which are expressed in smooth and cardiac muscle cells, calponin 3 is highly expressed in the brain. The goal of this study was to elucidate the spatiotemporal expression pattern of calponin 3 following repeated administration of 3-nitropropionic acid in mice. The repeated administration of 3-nitropropionic acid generated necrotic neuronal cell death in the striatum. Calponin 3 was up-regulated in the neuroprotective penimbral region from 1.5 days after the last injection and thereafter. Double immunofluorescence study revealed that calponin 3 was induced in GFAP-positive astrocytes. These results suggest that calponin 3 induction in the neuroprotective penumbral area following 3-nitropropionic acid intoxication may play a key role in reactive astrogliosis in the striatum.
Introduction
Calponin is an actin filament-associated regulatory protein expressed in diverse types of cells including smooth muscle cells. Three isoforms of calponin, calponin 1 (acidic calponin), calponin 2 (neutral calponin) and calponin 3 (acidic calponin) have been known in vertebrates. Although the role of calponin in regulating smooth muscle contractility has been extensively investigated, the function and regulation of calponin in non-muscle cells is much less understood [17] .
Calponin 1 and calponin 2 are predominately expressed in smooth muscle cells and cardiac muscle cells, respectively. On the other hand, calponin 3 is highly expressed in many tissues including articular cartilage and brain [6, 11] . In the central nervous system, calponin 3 is co-localized with PSD95, NR1 and GluR1. Postsynaptic over-expression of calponin 3 enhances the frequency of miniature excitatory postsynaptic currents by reorganizing the actin filaments [12] . These data indicate that calponin 3 may play an important role in regulating spine plasticity and synaptic activity.
Interestingly, it has been reported that the expression of calponin 3 is increased in the brain of epileptic patients and experimental rats. In addition, the elevation level of calponin 3 in the cerebrospinal fluid (CSF) was highly correlated with disease duration [7] . Further, calponin 3 immunoreactivity was clearly increased in the inner one-third of the molecular layer of the dentate gyrus at 1 and 2 weeks after pilocarpine-induced seizures, which indicates that calponin 3 is involved in mossy fiber sprouting and neo-synaptogenesis [5] . Taken together, it is believed that calponin 3 is involved in pathogenesis and remodeling of the central nervous system by regulating morphology of axon and dendrites, and its activity.
To further elucidate the role of calponin 3 in neuropathology, a mouse model of 3-nitropropionic acid (3-NP)-induced striatal neurotoxicity was employed. Systemic administration of 3-NP induces blockade of mitochondrial complex II and decreases ATP level within the brain, which preferentially induces excitotoxic striatal neurodegeneration with behavioral abnormalities reminiscent of Huntington's disease [1] [2] [3] 10] . In addition, the pattern of striatal lesions is similar to that seen in Huntington's disease patients. Therefore, 3-NP-induced striatal neurotoxicity is generally accepted as an animal model of HD-like symptoms. The present study was designed to investigate the involvement of calponin 3 in 3-NP-induced striatal neurotoxicity in mice. 
Materials and Methods

Animals
Male C57BL/6 mice (8 weeks old, Koatech, Kyungki-do, Korea) were housed at a standard temperature (22±1°C), humidity (50±1%), and in a light-controlled environment (lights on from 8:00 a.m. to 8:00 p.m.) with ad libitum access to food and water. The animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 80-23, revised 1996). Efforts were made to try to minimize animal suffering and to reduce the number of animals used.
3-nitropropionic acid (3-NP) intoxication
3-nitropropionic acid (3-NP, Sigma, St. Louis, MO) was dissolved in saline (25 mg/ml) and passed through a 0.2-μm filter. We followed the 3-NP injection protocol described by Huang et al. [8] . Briefly, 3-NP was injected intraperitoneally twice daily for 2 days at 12-h intervals (10:00 a.m. and 10:00 p.m.) at a dose of 60 mg/kg for the first two injections and 80 mg/kg for the second two injections. Animals were maintained on a standard 12-h light/dark cycle, with lights on at 8:00 a.m.
Tissue processing
Mice were anesthetized with 15% chloral hydrate and transcardially perfused with saline, followed by 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4. Brains were postfixed for 4 hours and then cryoprotected in 30% sucrose in 0.1 M PB. Sequential coronal sections (30 μm thick) through the striatum were prepared using a cryotome.
Immunohistochemistry and immunofluorescence
For immunohistochemical labeling, sections were blocked with 10% normal goat serum in PBS, followed by overnight incubation (4°C) with rabbit polyclonal anti-calponin 3 antibody (1:500; Santa Cruz, CA). Sections were then processed using the ABC staining method (Vector Laboratories, Burlingame, CA) and diaminobenzidine (DAB; Vector Laboratories) was used to visualize the signal.
For immunofluorescence labeling, sections were blocked with 10% normal goat serum, followed by overnight incubation with rabbit polyclonal anti-calponin 3 antibody (1:500) and mouse anti-GFAP antibody (1:500; Chemicon, Temecula, CA) or anti-NeuN antibody (1:500; Chemicon). Next, sections were incubated (2 h at room temperature) with secondary antibodies conjugated with Alexa 488 and Alexa 594 (1:1000; Invitrogen, San Diego, CA) and then mounted with Cytoseal (Richard-Allan Scientific, Kalamazoo, MI). Fluorescence images were captured using a Zeiss (Oberkochen, Germany) 510 Meta confocal microscope (2-μm-thick optical section).
Cresyl violet staining
In brief, sections were mounted on gelatin-coated slides and dried. After dehydrating in a graded alcohol series, sections were stained (20 min) with 0.1% cresyl violet solution. After destaining with solution of 95% ethanol and 0.1% glacial acetic acid, sections were dehydrated and mounted with Permount.
Results
Generation of 3-nitropropionic acid-induced striatal injury
As introduced in the previous report, 3-nitropropionic acid, a mitochondrial toxin, was used to induce striatal injury [4] . 3-nitropropionic acid was given at 12-h intervals as a dose of 60 mg/kg for the first two injections and 80 mg/kg for the second two. First, striatal damage was tested with cresyl violet which stains viable cells. As shown in Fig.  1 , marked tissue damage was observed in the lateral striatum at 3 days after last injection. The pattern of tissue damage was consistent between animals showing core region with concentrated neuronal damage. Increased expression of calponin 3 following 3-nitropionic acid-induced striatal damage Calponin 3 expression was examined by immunohistochemistry with calponin 3 antibody. As shown in Figs. 2A  and 2D , expression level of calponin 3 was low in normal tissue. However, slightly increased calponin 3 expression was observed at 1.5 days after last injection (Figs. 2B and  2E) . At 3 days after last injection strong expression of calponin 3 was observed in the striatum (Figs. 2C and 2F ). At this time point calponin 3 expression was strongly observed in the penumbral region where neurons are resistant to 3-nitropropionic acid injection. In contrast there was no regional pattern of calponin 3 expression at 1.5 days post last injection.
Induction of calponin 3 expression in reactive astrocyte
Next, double immunolabeling was performed to examine cell types expressing high levels of calponin 3. For this purpose antibodies against GFAF, an astrocytic marker, or NeuN, a neuronal marker, were used. As shown in Fig. 3A , calponin 3 expressing cells were not co-labeled with NeuN-positive neurons. On the other hand, calponin 3 was double-labeled with GFAP suggesting that calponin-3 is induced in reactive astrocytes following 3-nitropropionic acid-induced tissue damage.
Discussion
In this study, the initial finding was that calponin 3 is expressed in the striatum following 3-NP-induced striatal neurotoxicity. The expression of calponin 3 occurred at 1.5 days and thereafter, and its expression was preferentially observed in resistant penumbral areas rather than the necrotic core. In addition, calponin 3 was induced in GFAP-positive reactive astrocytes rather than in neurons.
Calponin was originally discovered in chicken gizzard smooth muscle as an actin-and calmodulin-binding protein [13] . It has been known that calponin interacts with F-actin, calmodulin, and tropomyosin, and functionally regulates the contraction and relaxation cycles in smooth muscle [14, 15] . In addition, calponin induces actin polymerization and stabilizes formed actin filaments resulting in the maintenance of stress fibers [9] . Although calponin 1 and 2 are predominantly expressed in smooth muscle cells, calponin 3 is highly expressed in the central nervous system and its expression level is increased in neuropathologic conditions such as epilepsy. In the central nervous system calponin 3 protein and its mRNA are mainly expressed in neurons under normal conditions [11] . Interestingly, calponin 3 is co-localized with PSD95, GluR1 and NR1 in the central nervous system and over-expression of calponin 3 in the cultured hippocampal neurons enhances the frequency of miniature ex-citatory postsynaptic currents. Thus, it has been postulated that calponin 3 is a key factor in regulating spine plasticity and synaptic activity [12] . One of the important findings in this study is that the expression of calponin 3 is strongly and predominantly induced in GFAP-positive reactive astrocytes in the resistant penumbral region following repeated 3-NP administration.
Intoxication with 3-NP results in asymmetric activation of transcriptional pathways, gene expression and cell vulnerability between neuroprotective penumbral and necrotic core regions. For example, the CREB/CRE-mediated transcriptional pathway is activated in the penumbral area but not in the necrotic core [4] . Likewise, the neuroprotective protein Bcl-2 is preferentially induced in neurons from the penumbral region and those neurons are protected [4] . Along these lines, in this study reactive astrocyte strongly expressing GFAP was preferentially observed in the penumbral region and these astrocytes were co-labeled with calponin 3. Previously, it has been reported that in case of epileptic patients expression level of calponin 3 was increased in MAP2-positive neurons [7] . In addition, in animal models of epilepsy with pilocarpine, calponin 3 immunoreactivity was specifically increased in the inner one-third of the molecular layer of the dentate gyrus and double immunolabeling revealed that calponin 3 was localized in the dendritic spines. Therefore, although there have been several reports showing calponin 3 expression in astrocytes under a normal state (see below), this is the first report showing strong induction of calponin 3 in astrocytes under pathologic conditions.
The expression of calponin 3 in astrocytes under normal conditions is controversial. For example, it was reported that calponin 3 is expressed in radial glia, glia limitans, Bergmann glia and mature astrocytes in postnatal rat brains, although it was absent in mature astrocytes in culture [11] . In addition, in the human cortices faint calponin-3 staining was reported in astrocytes [7] . Further, cultured cortical astrocytes express calponin heterogeneously [16] . Therefore, one may postulate that calponin 3 is highly expressed in the astrocyte during brain development and its expression level is gradually decreased. Supporting this idea, in this study calponin 3 immunoreactivity in the astrocytes was not evident under normal conditions. Next, the role of calponin 3 in reactive astrocyte is unclear. Astrocytes respond to CNS insults and change morphology, gene expression and form scars (which is called reactive astrogliosis). Thus, reactive astrocytes organize neuronal injury responses, inflammation, and repair. It has been reported that during development calponin 3 is observed at the growing tips of astrocytes, and this may suggest the role of calponin 3 in the elongation of glial processes [11] . Since elongation of processes is one of the main morphological changes in reactive astrocytes, enrichment of calponin 3 in reactive astrocytes is compatible with the hypothesis that calponin 3 contributes to the morphological maturation into reactive astrocytes following 3-NP-induced striatal neurotoxicity. However, further study will be needed to elucidate the role of calponin 3 in reactive astrocytes.
In summary, the data provided here reveal for the first time increased expression of calponin 3 in the astrocytes in the resistant penumbral region following 3-NP-induced neurotoxicity. Given the role of astrocytes during neurodegeneration, understanding the role of calponin 3 may provide insight into the striatal pathogenesis in HD and eventual therapeutic tools.
